• SPX
  • $5,762.48
  • 0.42 %
  • $24.31
  • DJI
  • $42,330.15
  • 0.04 %
  • $17.15
  • N225
  • $37,919.55
  • -4.8 %
  • -$1,910.01
  • FTSE
  • $8,236.95
  • -1.01 %
  • -$83.81
  • IXIC
  • $18,189.17
  • 0.38 %
  • $69.58
Ligand Pharmaceuticals Incorporated (LGND) Insider Traders

Ligand Pharmaceuticals Incorporated (LGND) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$99.97

$2.6

(2.67%)

Day's range
$97.06
Day's range
$100.33
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    1
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    5
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $243,481
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $9.42 M

Ligand Pharmaceuticals Incorporated Insider Transactions

Ligand Pharmaceuticals Incorporated Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Korenberg Matthew E

President & Chief Operating

Sell 520 @ $85.68 $44,556 86,263 05/14/2024 05/15/2024
Korenberg Matthew E

President & Chief Operating

Sell 3,440 @ $84.54 $290,828 100,421 05/13/2024 05/15/2024
Reardon Andrew

Chief Legal Officer &

Sell 10,000 @ $83.04 $830,449 22,205 05/09/2024 05/13/2024
Gray Nancy Ryan

Director

Sell 934 @ $83.20 $77,713 5,633 05/09/2024 05/17/2024
Sabba Stephen L

Director

Sell 1,893 @ $74.30 $140,650 28,926 03/05/2024 03/07/2024
Sell 140 @ $88.46 $12,384 29,755 02/28/2024 02/29/2024
Davis Todd C

Director, CHIEF EXECUTIVE OFFICER

Buy 4,000 @ $59.38 $237,529 73,090 09/22/2023 09/25/2023
KOZARICH JOHN W

Director

Sell 4,444 @ $77.20 $343,081 38,488 05/16/2023 05/18/2023
Sabba Stephen L

Director

Sell 6,408 @ $77.13 $494,225 25,784 05/10/2023 05/12/2023
KOZARICH JOHN W

Director

Sell 5,819 @ $76.51 $445,218 42,802 05/08/2023 05/10/2023
KOZARICH JOHN W

Director

Sell 589 @ $77.10 $45,410 42,213 05/08/2023 05/10/2023
Reardon Andrew

See Remarks

Sell 300 @ $69.92 $20,977 16,308 03/24/2023 03/28/2023

Ligand Pharmaceuticals Incorporated Frequently Asked Questions

  • Who is on Ligand Pharmaceuticals Incorporated's Insider Roster?

    The list of insiders at Ligand Pharmaceuticals Incorporated includes Espinoza Octavio, Sabba Stephen L, Gray Nancy Ryan, Reardon Andrew, Korenberg Matthew E, Davis Todd C.

  • How much insider selling is happening at Ligand Pharmaceuticals Incorporated?

    Insiders have sold a total of 99,783 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 9.42 M sold.

  • Which Ligand Pharmaceuticals Incorporated insiders have been selling company stock?

    The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Espinoza Octavio ($1.29 M), Sabba Stephen L ($140,650), Gray Nancy Ryan ($77,713), Reardon Andrew ($990,040), Korenberg Matthew E ($6.92 M),

  • How much insider buying is happening at Ligand Pharmaceuticals Incorporated?

    Insiders have purchased a total of 2,500 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 243,481 sold.

  • Which Ligand Pharmaceuticals Incorporated insiders have been buying company stock?

    The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($243,481),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.